Los Angeles, March 01, 2016 -- Theradome Inc., creator of the most technologically advanced and powerful OTC hair restoration device, will be showcasing its wearable laser helmet for female hair loss at the American Academy of Dermatology’s 74th Annual Meeting at the Walter E. Washington Convention Center in in Washington, D.C., March 4 through 6 at booth #3161. The company will be providing live demonstrations of its Theradome Laser Helmet and will have units available for sale.
In its utilization of Laser Phototherapy (also known as Low-Level Laser Light Therapy), the Theradome LH80 PRO Laser Helmet stimulates weak hair follicles that contribute to balding and/or thinning hair in women and men for over 97 percent of patients. Worn twice a week for 20 minutes, the device boosts the mitochondria and ATP production of follicles, leading to hair regrowth.
“Already, our clinical studies have shown how impactful the Theradome Laser Helmet is as a hair loss treatment for women. Now, we are conducting even more research that we are confident will prove similar results in men,” said Tamim Hamid, former NASA scientist, CEO and Founder of Theradome. “As one of the most lauded educational events in the field, the American Academy of Dermatology’s Annual Meeting is an ideal place for us to introduce our innovative technology to doctors and experts whose patients will benefit most.”
Unlike most hair restoration procedures, products, and devices that have been used by dermatologists in the past, the Theradome LH80 PRO Laser Helmet is unique in that it offers powerful, side effect-free, convenient and clinically proven solution to hair loss that can be administered in the comfort of patients’ homes.
Each year, thousands of dermatology professionals from all over the country gather at the industry meeting for a weekend of networking and education. With hair loss continuing to be a major issue for many dermatology patients, Theradome Inc. is anticipated to be a key exhibitor at this year’s event.
For more information, please visit www.theradome.com.
About Theradome
Theradome™ is a medical therapy company located in Silicon Valley, Calif., focused on developing the world’s most technologically advanced Laser Phototherapy devices along with complementary, superior scalp products. The company is committed to restoring health and confidence in people all around the globe by bringing affordable, clinical strength hair rejuvenation therapies into the home. The products developed by Theradome can minimize shedding, thicken existing hair and promote new hair growth for a fraction of the cost of visits to laser hair clinics.
Rachel Namson [email protected] Tyler Barnett PR 8484 Wilshire Blvd, Beverly Hills, CA 90211 323.937.1951


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



